Qlife Holding AB ("Qlife" or the "Company") is proud to announce that its Egoo Health blood testing platform will play a central role in a groundbreaking project launched by Hipro Biotechnology Co., ...
Individuals with prediabetes, which involves elevated blood glucose (sugar) levels that do not meet the criteria for a diabetes diagnosis, are at a very high risk of progressing to diabetes. Clinical ...
SHANGHAI (Reuters) -China's Innovent Biologics said on Monday its GLP-1 injection led to more weight loss and better control of blood sugar in patients with diabetes than injectable semaglutide, the ...
Lowering blood sugar levels to normal may cut the risk of serious heart problems by more than half in people with prediabetes ...
The findings suggest that intranasally delivered FGF-1 may reverse type 2 diabetes by targeting dysfunctional glucose-sensing ...
The condition doesn't have to be permanent for everyone, research suggests. After reviewing remission criteria, blood sugarguidelines, and recent clinical trials, the authors of the paper found that ...
Hua Medicine is developing potentially disease-modifying therapeutics for type 2 diabetes, driven by mechanisms in the glucose homeostasis process. Having launched dorzagliatin in China in 2022, the ...
A Stanford study confirmed a complete reversal of type 1 diabetes in mice through a combination of stem cell transplants and immune system therapies.
A team of researchers at the UCLA Health Jonsson Comprehensive Cancer Center has identified a potential new strategy to prevent, and even reverse, immune checkpoint inhibitor–induced type 1 diabetes, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback